Boston Harper Lecture: Engineering Immunotherapies for Cancer Thu., April 19, 2018 | 6:30 PM — 8:30 PM Omni Parker House 60 School St Boston, MA 02108 United States Sponsored By: UChicago Alumni Association Cancer arises from irregular cell growth, but tumors can also grow and metastasize through compromised immune systems. Cancer immunotherapy aims to train the immune system to destroy tumor cells and help it “remember” to attack those cells to prevent relapse. Melody Swartz of the Institute for Molecular Engineering will discuss this innovative and promising approach to tumor treatment, which requires ongoing research into changes in immune regulation in different types of cancer. To register or find out more information, please click here. Featured Faculty Melody A. Swartz is the William B. Ogden Professor of Molecular Engineering. She studies the lymphatic system and aims to understand, modulate, and exploit the complex roles of lymphatic vessels in immunity and pathophysiology, especially in cancer. Her lab aims to develop novel immunotherapeutic approaches to cancer, including vaccines that target lymph nodes. Swartz is a recipient of the MacArthur Fellowship, a Career Award from the National Science Foundation, an Arnold and Mabel Beckman Young Investigator Award, and the Wenner Prize—Switzerland’s largest prize for cancer research. To learn more about the entire Harper Lecture Series, please visit the UChicago Alumni Association's page. Questions? Contact alumniassociation@uchicago.edu or 773.702.2150. Recent News More news Announcing the 2024 Stone Center Thesis and Dissertation Award Winners Tue., July 02, 2024 Harris Voices: Viviana Martinez, CLA'20, on What It Means to "Crown Up" Tue., July 02, 2024 Natasha Mathur, MSCAPP’19, on the Connection Between the Real World and Data Tue., June 25, 2024
April 08, 2024 How Medicare beneficiaries with Part D plans can help ensure their medications are covered